{
    "nctId": "NCT00592462",
    "briefTitle": "Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases",
    "officialTitle": "Whole Body MRI for Detection of Cancer Metastases",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 32,
    "primaryOutcomeMeasure": "Develop and evaluate a whole body MRI technique for detecting cancer metastases.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Breast cancer patients with high suspicion or confirmed bone metastases.\n2. Patient who have undergone a clinically indicated skeletal scintigraphy within two weeks of the MRI exam.\n3. Patients who have signed their informed consent form to undergo the study.\n\nExclusion Criteria:\n\n1) Contraindication to conventional MR imaging (e.g. metal implants, pace maker, etc.).",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}